Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland chinese kazakh, uygur and han populations

Journal of Human Genetics

Volumn 54, Issue 6, 2009, Pages 372-375

  Wang, Shu Mei ^a   Zhu, An Ping ^b   Li, Dan ^a   Wang, Zhen ^b   Zhang, Ping ^b   Zhang, Guo Liang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Department of Outpatient Clinic   (China)

Author keywords

CYP2C19; CYP2E1; Genetic polymorphisms; Han; Kazakh; Mainland Chinese; Uygur

Indexed keywords

CYTOCHROME P450 2C19; CYTOCHROME P450 2E1;

ALLELE; ARTICLE; CHINA; CHINESE; ETHNIC DIFFERENCE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ARYL HYDROCARBON HYDROXYLASES; ASIAN CONTINENTAL ANCESTRY GROUP; CYTOCHROME P-450 CYP2E1; GENE FREQUENCY; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 67650813139     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2009.41     Document Type: Article

References (17)

1. Evans, W. E. Pharmacogenomics: marshalling the human genome to individualise drug therapy. Gut 52, ii10-ii18 (2003).
2. Griese, E. U., Ilett, K. F., Kitteringham, N. R., Eichelbaum, M., Powell, H., Spargo, R. M. et al. Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in Aborigines from Western Australia. Pharmacogenetics 11, 69-76 (2001).
3. Kóbori, L., Kõhalmy, K., Porrogi, P., Sárváry, E., Gerlei, Z., Fazakas, J. et al. Drug-induced liver graft toxicity caused by cytochrome P450 poor metabolism. Br. J. Clin. Pharmacol. 65, 428-436 (2008).
4. Bertilsson, L. Geographic/interracial differences in polymorphic drug oxidation: current state of the knowledge of cytochrome P450 (CYP) 2D6 and 2C19. Clin. Pharmacokinet. 29, 192-209 (1995).
5. Ghodke, Y., Joshi, K., Arya, Y., Radkar, A., Chiplunkar, A., Shintre, P. et al. Genetic polymorphism of CYP2C19 in Maharashtrian population. Eur. J. Epidemiol. 22, 907-915 (2007).
6. Shu, Y. & Zhou, H. H. Individual and ethnic differences in CYP2C19 activity in Chinese populations. Acta. Pharmacol. Sin. 21, 193-199 (2000).
7. Lee, S. S., Lee, S. J., Gwak, J., Jung, H. J., Thi-Le, H., Song, I. S. et al. Comparison of CYP2C19 genetic polymorphisms between Korean and Vietnamese populatons. Ther. Drug Monit. 29, 455-459 (2007).
8. Munaka, M., Kohshi, K., Kawamoto, T., Takasawa, S., Nagata, N., Itoh, H. et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 129, 355-360 (2003).
9. Verlaan, M., Te Morsche, R. H., Roelofs, H. M., Laheij, R. J., Jansen, J. B., Peters, W. H. et al. Genetic polymorphisms in alcohol metabolizing enzymes and chronic pancreatitis. Alcohol 39, 20-24 (2004).
10. Vidal, F., Lorenzo, A., Auguet, T., Olona, M., Broch, M., Gutiérrez, C. et al. Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in spanish men: lack of association with alcoholism and alcoholic liver disease. J. Hepatol. 41, 744-750 (2004).
11. Li, D., Zhang, G. L., Lou, Y. Q., Li, Q., Wang, X. & Bu, X. Y. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups. J. Clin. Pharm. Ther. 32, 89-95 (2007).
12. Niu, C. Y., Luo, J. Y. & Hao, Z. M. Genetic polymorphism analysis of cytochrome P450 2C19 in Chinese Uigur and Han populations. Chin. J. Dig. Dis. 5, 76-80 (2004).
13. Liou, Y. H., Lin, C. T., Wu, Y. J. & Wu, L. S. The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population. J. Hum. Genet. 51, 857-863 (2006).
14. Chen, L., Qin, S., Xie, J., Tang, J., Yang, L., Shen, W. et al. Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China. Pharmacogenomics 9, 691-702 (2008).
15. Scordo, M. G., Caputi, A. P., D'Arrigo, C., Fava, G. & Spina, E. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. Pharmaco. Res. 50, 195-200 (2004).
16. Katsuyama, Y., Inoko, H., Imanishi, T., Mizuki, N., Gojobori, T. & Ota, M. Genetic relationships among Japanese, Northern Han, Hui, Uygur, Kazakh, Greek, Saudi Arabian, and Italian populations based on allelic frequencies at four VNTR (D1S80, D4S43, COL2A1, D17S5) and one STR (ACTBP2) Loci. Hum. Hered. 48, 126-137 (1998).
17. Makeeva, O., Stepanov, V., Puzyrev, V., Goldstein, D. B. & Grossman, I. Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes. Pharmacogenomics 9, 847-868 (2008).